Qiang Ma

Sep 27, 2024 | mdpi.com | qian Xu |Qiang Ma

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Jul 28, 2024 | onlinelibrary.wiley.com | Huanhuan Wang |Yan Sun |Qiang Ma |Yi Feng

Conflict of Interest The authors declare no conflict of interest. Supporting Information Filename Description adma202406143-sup-0001-SuppMat.docx3.4 MB Supporting Information References 1a) , , , , , , , , , , , , Sci. Transl. Med. 2010, 2, 53ra74; b) , , , , , , , , , , , , , Nat. Commun. 2022, 13, 4455; c) , , , , , , , , , , , , , , , , , , , , Nat. Nanotechnol. 2024, 19, 834. 2a) , , , , , , , , , , , , , , , , , , Sci. Transl. Med. 2020, 12, eaay0233; b) , , , , , J. Exp. Med.

Jul 18, 2024 | mdpi.com | Qiang Ma |Jianyu Li |Lin Liu |Xuesong Lu

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Apr 19, 2024 | mdpi.com | Min Zeng |Zhiqiang Wang |Ying Xu |Qiang Ma

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Feb 15, 2024 | molecular-cancer.biomedcentral.com | Bo Huang |Qiang Ma |Feifei Yang |Xiaojuan Pan |Yuying Zhang |Yuying Liu | +8 more

We collected 152 paired human ccRCC and adjacent nontumor tissues (4 paired tissues for screening phase and 148 paired tissues for validation phase) from the Southwest Hospital of the Army Medical University (Chongqing, China, 2019–2022). Clinical characteristics are listed in Supplementary Table S1-2. The diagnosis of ccRCC was confirmed via histopathological examination. This study was approved by the Ethics Committee of Southwest Hospital of Army Medical University (approval number: KY2020121).